Skip to content

Menthol and Mint Experimental Tobacco Marketplace (ETM) Study

The Impact of Menthol and Mint E-liquid Bans on Menthol Cigarette Smokers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04879225
Enrollment
66
Registered
2021-05-10
Start date
2021-06-21
Completion date
2022-12-29
Last updated
2024-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cigarette Smoking, Vaping

Keywords

smoking, menthol, mint, vaping, menthol ban

Brief summary

Menthol cigarettes comprise almost one-third of the United States (US) market share and are disproportionately smoked by racial minorities. Tobacco control policies targeting menthol flavoring in tobacco could have significant public health outcomes, especially among black smokers. One key challenge of tobacco regulation is weighing the risks and benefits of potential policies across different populations (i.e., users and non-users). Tension arises between policies intended to prevent adolescent and young adult (AYA) tobacco initiation and those intended to reduce harm among current tobacco users. The availability of menthol e-liquids may be important for encouraging menthol cigarette smokers to switch to e- cigarettes, but mint e-liquids, which are appealing to AYA, may be unnecessary to facilitate switching. Including mint e-liquids in flavor bans but allowing menthol e-liquids to remain on the market as potential substitution products for menthol smokers may be an optimal policy approach. The study team is proposing a lab study and field assessment to determine how including menthol and mint e-liquids in e-liquid flavor bans or sales restrictions affects tobacco product purchasing and use among menthol cigarette smokers. At lab sessions, participants will complete the Experimental Tobacco Marketplace (ETM) task, a behavioral economics task in which they receive account balances to an online store and can buy menthol cigarettes at escalating costs or buy e-liquids, non-menthol cigarettes, or nicotine replacement gum at fixed costs. They will complete the task under four marketplace conditions: (1) only tobacco e-liquids available, (2) menthol and tobacco e-liquids available, (3) menthol, mint, and tobacco e-liquids available, and (4) tobacco, menthol, mint, fruit, dessert. During a field assessment, product choice is validated by assessing use of products purchased during the ETM task. This proposal will inform policy-makers about the impact banning menthol and mint e-liquids will have on facilitating menthol cigarette smokers switching to e-cigarettes.

Detailed description

The study team proposes to conduct a within-subjects, multi-session virtual lab study and validation field assessment to determine how the availability of menthol and mint e-liquids affects product purchasing among menthol cigarette smokers. Adult daily menthol cigarette smokers will be recruited for this study. After initial eligibility is assessed, participants will complete six virtual sessions and one field assessment to evaluate their tobacco use. Participants will be recruited from Winston-Salem, North Carolina (NC) and the surrounding area using advertisements on public transit, community flyers, and social media. Curbside visits to drop off biosamples and pickup study products will be conducted outside the Wake Forest Tobacco Control Center of Excellence located in Biotech Place in the Innovation Quarter. The study team anticipates recruiting up to 100 participants to achieve 80 completers. Equal numbers of black and white participants will be enrolled.

Interventions

BEHAVIORALTobacco e-liquids

Marketplace includes tobacco flavored e-liquids

BEHAVIORALMenthol and Tobacco e-liquids

Marketplace includes menthol and tobacco flavored e-liquids

BEHAVIORALMint, Menthol and Tobacco e-liquids

Marketplace includes mint, menthol and tobacco flavored e-liquids

BEHAVIORALAll e-liquid flavors

Marketplace includes fruit, dessert, mint, menthol and tobacco flavored e-liquids

Sponsors

Wake Forest University Health Sciences
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
OTHER
Masking
NONE

Intervention model description

Participants will experience four marketplace conditions that differ in the availability of flavored e-liquids.

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. 21+ years of age 2. Self-report smoking at least 5 cigarettes per day for the past year 3. Self-report smoking menthol cigarette brands \> 80% of the time 4. Breathe carbon monoxide (CO) level \> 8 ppm Willingness to use other tobacco products during the study 5. Speak, comprehend, and read English sufficiently to complete study procedures 6. Have home access to a computer or tablet with a web camera and internet access

Exclusion criteria

1. Currently seeking treatment to quit smoking 2. Self-reported serious medical or psychiatric condition(s) including cardiovascular and chronic respiratory diseases 3. Body temperature \> 100.4 F 4. Cold, flu or Novel Coronavirus (COVID-19) symptoms including fever, cough, and runny nose in the past 30 days 5. Currently pregnant, breastfeeding or intending to become pregnant for the duration of the study or unwilling to agree to use adequate protection to avoid pregnancy 6. CO reading \> 80 ppm 7. Enrollment stratum (Non-Hispanic, white or Black/African American)

Design outcomes

Primary

MeasureTime frameDescription
Total Amount of Combusted Tobacco PurchasedDay 3Total amount of non-menthol cigarettes purchased when menthol cigarettes are not available.

Secondary

MeasureTime frameDescription
Total Amount of E-liquid PurchasedDay 3, Day 4, Day 5, Day 6Total amount of e-liquid purchased when menthol cigarettes are not available.

Other

MeasureTime frameDescription
Total Amount of Tobacco E-liquid PurchasedDay 3, Day 4, Day 5, Day 6Total amount of tobacco e-liquid purchased when menthol cigarettes are not available according to race.
Total Amount of Menthol E-liquid PurchasedDay 3, Day 4, Day 5, Day 6Total amount of menthol e-liquid purchased when menthol cigarettes are not available according to race.
Total Amount of Dessert/Fruit E-liquid Purchased.Day 3, Day 4, Day 5, Day 6Total amount of dessert/fruit e-liquid purchased when menthol cigarettes are not available according to race.
Themes Emerging From the Qualitative InterviewsDay 14Qualitative interviews will be conducted and then analyzed in an effort to learn common themes or trends among the participants specific to various tobacco and nicotine products.
Mean Perceived Health Risk Scale ScoreBaseline, Day 14This is a measure of the perceived addictive potential and other health risks associated with cigarettes, e-cigarettes and nicotine gum. Scale 1-10 (1=very low risk of disease and 10=very high risk of disease). Each item/question has a score of 1-10. There are 14 different items in this questionnaire and each item will be evaluated independently.
Total Amount of Mint E-liquid PurchasedDay 3, Day 4, Day 5, Day 6Total amount of mint e-liquid purchased when menthol cigarettes are not available according to race.
Mean Minnesota Nicotine Withdrawal Scale ScoreBaseline, Day 3, Day 4, Day 5, Day 6, Day 14This is a 15-item self-reported scale to evaluate the effects of smoking cessation and withdrawal symptoms. This scale is important because it allows the researchers to understand the experience of the participant throughout the study while using various tobacco products. The study team will use 7/15 items from this scale each ranging in score from 1-5. Total score range for the questionnaire would be 7-35 with higher score denoting more severe symptoms.
Mean Questionnaire on Smoking Urges ScoreBaseline, Day 3, Day 4, Day 5, Day 6, Day 14This scale measures the person's urge to smoke throughout the study while potentially using various tobacco and nicotine products. This questionnaire consists of 10 items each ranging from 1-7. Total score range for the entire questionnaire is 10-70. A higher score denotes greater urge.
Mean Tobacco Product Interest ScoresBaseline, Day 14A visual analog scale assessing interest in use of various tobacco and nicotine products. Each item has a score from 0-100. This scale ranges from no interest (0) to very interested (100). The total questionnaire has 9 items that will be evaluated independently. The study team is looking at the following: 1. Preferred cigarette brand 2. Any other cigarette brand 3. A cigarette brand with 95% less nicotine 4. I Quit Ordinary Smoking (IQOS) Heat-Not-Burn Device 5. Juice Universal Serial Bus Lighting (JUUL) Vaping Device 6. Zyn Nicotine Pouches 7. NicoDerm Nicotine Patch 8. Nicorette Nicotine Lozenge 9. Nicorette Nicotine Gum
Tobacco Policy Questionnaire ScoreBaseline, Day 14A visual analog scale assessing interest in use of various tobacco and nicotine products. This questionnaire will assess support for various tobacco control policies, including banning menthol flavoring in cigarettes and e-cigarettes. Each of the 14 items has a score of 1-3. 1 means the subject is supportive of the policy, 2 means subject is opposed. 3 indicates that the subject does not know. Each of the 14 items will be evaluated independently from one another.
Mean Product Evaluation Scale ScoreBaseline, Day 14This scale measures the participant's experience while using cigarettes, nicotine gum, or vaping devices. Each of the three products will include 13 items with a total score range of 13-91 for each of the three products. A higher score denotes more enjoyment from the product.
Total Amount of Non-menthol CigarettesDay 3, Day 4, Day 5, Day 6Total amount purchased when menthol cigarettes are not available according to race

Countries

United States

Participant flow

Pre-assignment details

14 participants screen failed prior to enrolling.

Participants by arm

ArmCount
E-liquid Availability
Flavor availability is manipulated Tobacco e-liquids: Marketplace includes tobacco flavored e-liquids Menthol and Tobacco e-liquids: Marketplace includes menthol and tobacco flavored e-liquids Mint, Menthol and Tobacco e-liquids: Marketplace includes mint, menthol and tobacco flavored e-liquids All e-liquid flavors: Marketplace includes fruit, dessert, mint, menthol and tobacco flavored e-liquids
52
Total52

Withdrawals & dropouts

PeriodReasonFG000
Menthol and TobaccoLost to Follow-up1
Mint, Menthol, TobaccoLost to Follow-up1

Baseline characteristics

CharacteristicE-liquid Availability
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
52 Participants
Age, Continuous44.9 years
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
51 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
33 Participants
Race (NIH/OMB)
More than one race
1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
Race (NIH/OMB)
White
17 Participants
Region of Enrollment
United States
52 participants
Sex: Female, Male
Female
28 Participants
Sex: Female, Male
Male
24 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 52
other
Total, other adverse events
0 / 52
serious
Total, serious adverse events
0 / 52

Outcome results

Primary

Total Amount of Combusted Tobacco Purchased

Total amount of non-menthol cigarettes purchased when menthol cigarettes are not available.

Time frame: Day 4

Population: 2 participants were excluded from data analysis due to receiving incorrect shopping links. 1 participant was lost to follow up.

ArmMeasureValue (MEAN)Dispersion
E-liquid AvailabilityTotal Amount of Combusted Tobacco Purchased1185.9 mgStandard Deviation 1510.4
Primary

Total Amount of Combusted Tobacco Purchased

Total amount of non-menthol cigarettes purchased when menthol cigarettes are not available.

Time frame: Day 5

Population: 2 participants were excluded from data analysis due to receiving incorrect shopping links. 1 participant was lost to follow up.

ArmMeasureValue (MEAN)Dispersion
E-liquid AvailabilityTotal Amount of Combusted Tobacco Purchased1154.1 mgStandard Deviation 1839.6
Primary

Total Amount of Combusted Tobacco Purchased

Total amount of non-menthol cigarettes purchased when menthol cigarettes are not available.

Time frame: Day 6

Population: 2 participants were excluded from data analysis due to receiving incorrect shopping links.

ArmMeasureValue (MEAN)Dispersion
E-liquid AvailabilityTotal Amount of Combusted Tobacco Purchased1318.2 mgStandard Deviation 1678.6
Primary

Total Amount of Combusted Tobacco Purchased

Total amount of non-menthol cigarettes purchased when menthol cigarettes are not available.

Time frame: Day 3

Population: 2 participants were excluded from data analysis due to receiving incorrect shopping links.

ArmMeasureValue (MEAN)Dispersion
E-liquid AvailabilityTotal Amount of Combusted Tobacco Purchased990.6 mgStandard Deviation 1756.9
Secondary

Total Amount of E-liquid Purchased

Total amount of e-liquid purchased when menthol cigarettes are not available.

Time frame: Day 3, Day 4, Day 5, Day 6

Population: All active participants went through all four interventions on four different days.

ArmMeasureGroupValue (MEAN)Dispersion
E-liquid AvailabilityTotal Amount of E-liquid PurchasedDay 39.8 MgStandard Deviation 26.2
Intervention 2: Mint, Menthol, and TobaccoTotal Amount of E-liquid PurchasedDay 413.1 MgStandard Deviation 36.4
Intervention 3: Menthol and TobaccoTotal Amount of E-liquid PurchasedDay 522.4 MgStandard Deviation 47.8
Intervention 4: Only TobaccoTotal Amount of E-liquid PurchasedDay 630.2 MgStandard Deviation 56.5
Other Pre-specified

Mean Minnesota Nicotine Withdrawal Scale Score

This is a 15-item self-reported scale to evaluate the effects of smoking cessation and withdrawal symptoms. This scale is important because it allows the researchers to understand the experience of the participant throughout the study while using various tobacco products. The study team will use 7/15 items from this scale each ranging in score from 1-5. Total score range for the questionnaire would be 7-35 with higher score denoting more severe symptoms.

Time frame: Baseline, Day 3, Day 4, Day 5, Day 6, Day 14

Other Pre-specified

Mean Perceived Health Risk Scale Score

This is a measure of the perceived addictive potential and other health risks associated with cigarettes, e-cigarettes and nicotine gum. Scale 1-10 (1=very low risk of disease and 10=very high risk of disease). Each item/question has a score of 1-10. There are 14 different items in this questionnaire and each item will be evaluated independently.

Time frame: Baseline, Day 14

Other Pre-specified

Mean Product Evaluation Scale Score

This scale measures the participant's experience while using cigarettes, nicotine gum, or vaping devices. Each of the three products will include 13 items with a total score range of 13-91 for each of the three products. A higher score denotes more enjoyment from the product.

Time frame: Baseline, Day 14

Other Pre-specified

Mean Questionnaire on Smoking Urges Score

This scale measures the person's urge to smoke throughout the study while potentially using various tobacco and nicotine products. This questionnaire consists of 10 items each ranging from 1-7. Total score range for the entire questionnaire is 10-70. A higher score denotes greater urge.

Time frame: Baseline, Day 3, Day 4, Day 5, Day 6, Day 14

Other Pre-specified

Mean Tobacco Product Interest Scores

A visual analog scale assessing interest in use of various tobacco and nicotine products. Each item has a score from 0-100. This scale ranges from no interest (0) to very interested (100). The total questionnaire has 9 items that will be evaluated independently. The study team is looking at the following: 1. Preferred cigarette brand 2. Any other cigarette brand 3. A cigarette brand with 95% less nicotine 4. I Quit Ordinary Smoking (IQOS) Heat-Not-Burn Device 5. Juice Universal Serial Bus Lighting (JUUL) Vaping Device 6. Zyn Nicotine Pouches 7. NicoDerm Nicotine Patch 8. Nicorette Nicotine Lozenge 9. Nicorette Nicotine Gum

Time frame: Baseline, Day 14

Other Pre-specified

Themes Emerging From the Qualitative Interviews

Qualitative interviews will be conducted and then analyzed in an effort to learn common themes or trends among the participants specific to various tobacco and nicotine products.

Time frame: Day 14

Other Pre-specified

Tobacco Policy Questionnaire Score

A visual analog scale assessing interest in use of various tobacco and nicotine products. This questionnaire will assess support for various tobacco control policies, including banning menthol flavoring in cigarettes and e-cigarettes. Each of the 14 items has a score of 1-3. 1 means the subject is supportive of the policy, 2 means subject is opposed. 3 indicates that the subject does not know. Each of the 14 items will be evaluated independently from one another.

Time frame: Baseline, Day 14

Other Pre-specified

Total Amount of Dessert/Fruit E-liquid Purchased.

Total amount of dessert/fruit e-liquid purchased when menthol cigarettes are not available according to race.

Time frame: Day 3, Day 4, Day 5, Day 6

Other Pre-specified

Total Amount of Menthol E-liquid Purchased

Total amount of menthol e-liquid purchased when menthol cigarettes are not available according to race.

Time frame: Day 3, Day 4, Day 5, Day 6

Other Pre-specified

Total Amount of Mint E-liquid Purchased

Total amount of mint e-liquid purchased when menthol cigarettes are not available according to race.

Time frame: Day 3, Day 4, Day 5, Day 6

Other Pre-specified

Total Amount of Non-menthol Cigarettes

Total amount purchased when menthol cigarettes are not available according to race

Time frame: Day 3, Day 4, Day 5, Day 6

Other Pre-specified

Total Amount of Tobacco E-liquid Purchased

Total amount of tobacco e-liquid purchased when menthol cigarettes are not available according to race.

Time frame: Day 3, Day 4, Day 5, Day 6

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026